PhRMA lobbies for drug discount program to be constrained

The leading US trade group for the pharmaceuticals industry is lobbying for the federal 340B drug discount program to be constrained.

Created in 1992, the program requires drug manufacturers in the USA to discount outpatient drugs for certain public or nonprofit healthcare providers, such as children’s hospitals and rural referral centers.

In a blog post, the Pharmaceutical Research and Manufacturers of America (PhRMA) said the scheme is: “Now benefiting wealthy hospitals instead of patients.”